drugset / Trial / NCT02514122

Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda

NCT02514122

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized double blind control trial to investigate the safety and efficacy of subcutaneous ketamine for control of post operative pain in low resource settings.

Timeline

Start
2015-06
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 1 mg/kg Subcutaneous

Indications

No indication recorded.